SAN
DIEGO, Nov. 7, 2022 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, announced today the commercial
launch of the NuVasive Tube System (NTS) and Excavation Micro, a
new minimally invasive surgery (MIS) system that provides
comprehensive solutions for both TLIF and decompression. These
additions expand the Company's access and instrumentation
technology offerings within the NuVasive P360 portfolio.
"There's a clear opportunity to transform surgery within the
$1.7 billion-dollar thoracolumbar
posterior procedure segment and we're seizing it with P360,"
said Ryan Donahoe, chief technology officer at NuVasive.
"Our P360 portfolio is now complemented by the launch of our NTS
and Excavation Micro solutions that are specifically designed to
increase workflow speed while delivering improved safety and
reproducibility."
Engineered to elevate the surgical workflow through efficient,
controlled positioning, and optimized access, NTS and Excavation
Micro are made a complete procedural solution with Advanced
Materials Science and expandable interbody implants, biologics,
Reline fixation system, and enabling technologies within the Pulse
platform.
"The tube systems on the market haven't really changed much in
the past 20 years. Now with NTS, I'm able to tackle two procedures
with the same system through the incredible access design—which
further extends NuVasive as the market leader in access
innovation," said Dr. David Yam,
neurosurgeon in Portland, Oregon
at Legacy Medical Group. "Even with more complex surgeries,
I'm able complete the case through a tube, rather than reverting to
an open procedure."
NuVasive will feature its P360 portfolio at the upcoming
NuVasive Innovation Event. On November
16, join NuVasive virtually to
hear Company leadership and surgeon partners
discuss all comprehensive procedural portfolios—P360, X360,
C360, complex, and the enabling technologies within Pulse. Hear
from surgeons on NTS, and their experiences with the comprehensive
P360 portfolio addressing everything from open TLIFs to MAS Midline
procedures.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, with a mission to transform surgery, advance care, and
change lives. The Company's less-invasive, procedurally integrated
surgical solutions are designed to deliver reproducible and
clinically proven outcomes. The Company's comprehensive procedural
portfolio includes surgical access instruments, spinal implants,
fixation systems, biologics, software for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available at
www.sec.gov. NuVasive assumes no obligation to update any
forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-launches-tube-system-and-excavation-micro-for-posterior-spine-surgery-301669647.html
SOURCE NuVasive, Inc.